Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease.

被引：0
|
作者：
Straus, DJ [1 ]
Yahalom, J [1 ]
Zelenetz, AD [1 ]
Qin, J [1 ]
Myers, J [1 ]
Moskowitz, CH [1 ]
Noy, A [1 ]
Bertino, JR [1 ]
Portlock, CS [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3201
引用
收藏
页码：769A / 769A
页数：1
相关论文
共 50 条
  • [41] A randomized phase III comparison of single-modality ABVD with a strategy that includes radiation therapy in patients with early-stage Hodgkin's disease: The HD-6 trial of the National Cancer Institute of Canada Clinical Trials Group (Eastern Cooperative Oncology Group Trial JHD06).
    Meyer, R
    Gospodarowicz, M
    Connors, J
    Pearcey, R
    Bezjak, A
    Wells, W
    Burns, B
    Winter, J
    Horning, S
    Dar, R
    Djurfeld, M
    Shepherd, L
    Ding, KY
    BLOOD, 2003, 102 (11) : 26A - 26A
  • [42] Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease:: Long-term results of a randomized trial of radiotherapy alone
    Dühmke, E
    Franklin, J
    Pfreundschuh, M
    Sehlen, S
    Willich, N
    Rühl, U
    Müller, RP
    Lukas, P
    Atzinger, A
    Paulus, U
    Lathan, B
    Rüffer, U
    Sieber, M
    Wolf, J
    Engert, A
    Georgii, A
    Staar, S
    Herrmann, R
    Beykirch, M
    Kirchner, H
    Emminger, A
    Greil, R
    Fritsch, E
    Koch, P
    Drochtert, A
    Brosteanu, O
    Hasenclever, D
    Loeffler, M
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2905 - 2914
  • [43] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's disease:: interim results of the German Hodgkin's Lymphoma Study Group (GHSG) trial hd10
    Müller, RP
    Eich, HT
    Wolf, J
    Pfistner, B
    Engert, A
    Diehl, V
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S205 - S205
  • [44] CHOP alone compared to CHOP plus radiotherapy foe early stage aggressive non-Hodgkin's lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial.
    Miller, TP
    Leblanc, M
    Spier, C
    Chase, E
    Fischer, RI
    BLOOD, 2001, 98 (11) : 724A - 725A
  • [45] RADIATION-THERAPY VERSUS COMBINATION CHEMOTHERAPY IN THE TREATMENT OF EARLY-STAGE HODGKINS-DISEASE - 7-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
    LONGO, DL
    GLATSTEIN, E
    DUFFEY, PL
    YOUNG, RC
    HUBBARD, SM
    URBA, WJ
    WESLEY, MN
    RAUBITSCHEK, A
    JAFFE, ES
    WIERNIK, PH
    DEVITA, VT
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (06) : 906 - 917
  • [46] VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial
    Donaldson, SS
    Hudson, MM
    Lamborn, KR
    Link, MP
    Kun, L
    Billett, AL
    Marcus, KC
    Hurwitz, CA
    Young, JA
    Tarbell, NJ
    Weinstein, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3081 - 3087
  • [47] End results of a prospective clinical trial with VAMP and low-dose, involved-field radiation for pediatric patients with favorable, early-stage Hodgkin's disease
    Donaldson, S
    Tarbell, N
    Weinstein, H
    Link, M
    Kun, L
    Billett, A
    Marcus, K
    Hurwitz, C
    Young, J
    Brain, S
    Hudson, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S21 - S21
  • [48] ADJUVANT CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE CHEMOTHERAPY AFTER RADIATION-THERAPY IN STAGE-I LOW-GRADE AND INTERMEDIATE-GRADE NON-HODGKIN LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED STUDY
    YAHALOM, J
    VARSOS, G
    FUKS, Z
    MYERS, J
    CLARKSON, BD
    STRAUS, DJ
    CANCER, 1993, 71 (07) : 2342 - 2350
  • [49] SWOG/NRG S1914: A Randomized Phase III Trial of Induction/Consolidation Atezolizumab plus SBRT vs. SBRT Alone in High Risk, Early-Stage NSCLC (NCT#04214262)
    Daly, M. E.
    Redman, M.
    Simone, C. B., II
    Monjazeb, A. M.
    Bauman, J. R.
    Hesketh, P.
    Feliciano, J.
    Kashani, R.
    Steuer, C.
    Ganti, A. K.
    Jieling, M.
    Moon, J.
    Hu, C.
    Bradley, J. D.
    Kelly, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E414 - E414
  • [50] Androgen suppression plus radiation versus radiation alone for patients with stage D1/Pathologic node-positive adenocarcinoma of the prostate:: Updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31
    Lawton, CA
    Winter, K
    Grignon, D
    Pilepich, MV
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 800 - 807
12345